News | September 09, 2008

Carestream Molecular Imaging Expands Global Presence

September 10 — Carestream Molecular Imaging, a division of Carestream Health, Inc.is expanding its international presence with new dealer partnerships and a growing worldwide customer base, adding new dealer partners in Europe and the Middle East, the company reported at this week’s World Molecular Imaging Conference in Nice, France.

As part of its strategy to fill the demand for a cost effective and translatable molecular imaging solutions, the molecular imaging division has established new dealer partnerships with BioNova Cientifica, S.l. in Spain, Biosense S.R.L. in Italy, Csertex KFT in Hungary, and TransOrient Trading Co. in Palestine.

The company’s European dealer network is dedicated to increasing the presence of the company’s optical molecular imaging systems and fluorescent imaging agents to prominent pharmaceutical companies and research institutions. Partners such as Advanced Molecular Vision Ltd., AMV Germany, BioTech a.s., Csertex Ltd., Metis Biyoteknoloji and Metis-Turkey have been instrumental in the company’s recent customer successes in the following European institutions, such as Baxter AG, Charles University of Prague, Imperial College London’s Kennedy Institute of Rheumatology and several others.

Carestream Molecular Imaging is showcasing its portfolio of in vivo digital molecular imaging systems and imaging agents at the 2008 World Molecular Imaging Conference.
Carestream Health, an independent company, has licensed the KODAK brand for use with its own brands across its portfolio of leading-edge molecular imaging, medical imaging and healthcare IT products.

For more information: mi.carestreamhealth.com

Related Content

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Shine Medical Technologies Breaks Ground on U.S. Medical Isotope Production Facility

Image courtesy of Amen Clinics

News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor
Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S...
A 3-D printed tungsten X-ray system collimator. 3D printed, additive manufacturing for medical imaging.

A 3-D printed tungsten X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix. 

Feature | Medical 3-D Printing | April 29, 2019 | By Steve Jeffery
In ...
NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...